Gain Therapeutics (GANX) Enterprise Value: 42.13M

Gain Therapeutics, Inc. (GANX)

1.26 -0.03 (-2.33%) USD | NASDAQ | Oct 23, 16:00

1.33 +0.07 (+5.56%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2021. Start Trial.

Date	Value
October 23, 2026	42.13M
October 22, 2026	43.44M
October 21, 2026	39.10M
October 20, 2026	39.10M
October 19, 2026	41.70M
October 16, 2026	42.13M
October 15, 2026	45.17M
October 14, 2026	44.74M
October 13, 2026	48.64M
October 12, 2026	55.57M
October 09, 2026	58.60M
October 08, 2026	57.52M
October 07, 2026	59.90M
October 06, 2026	59.90M
October 05, 2026	60.77M
October 02, 2026	61.64M
October 01, 2026	62.07M
September 30, 2026	62.50M
September 29, 2026	60.34M
September 28, 2026	64.24M
September 25, 2026	64.67M
September 24, 2026	67.27M
September 23, 2026	67.27M
September 22, 2026	72.04M
September 21, 2026	67.27M

Date	Value
September 18, 2026	63.81M
September 17, 2026	64.67M
September 16, 2026	62.07M
September 15, 2026	61.64M
September 14, 2026	62.94M
September 11, 2026	63.37M
September 10, 2026	61.64M
September 09, 2026	62.07M
September 08, 2026	66.84M
September 04, 2026	65.54M
September 03, 2026	66.41M
September 02, 2026	65.11M
September 01, 2026	64.24M
August 31, 2026	65.54M
August 28, 2026	64.24M
August 27, 2026	67.71M
August 26, 2026	65.97M
August 25, 2026	70.09M
August 24, 2026	74.21M
August 21, 2026	74.42M
August 20, 2026	73.34M
August 19, 2026	77.24M
August 18, 2026	75.51M
August 17, 2026	75.94M
August 14, 2026	79.41M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks